1. Home
  2. Labeler Index
  3. Viiv Healthcare Company
  4. 49702-213
  5. NDC Package Code: 49702-213-26 Retrovir

NDC Package 49702-213-26 Retrovir

Zidovudine Injection, Solution Intravenous - View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. NDC HCPCS Crosswalk
    3. Frequently Asked Questions

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
49702-213-26
Package Description:
5 VIAL, SINGLE-USE in 1 CARTON / 20 mL in 1 VIAL, SINGLE-USE (49702-213-01)
Product Code:
49702-213
Proprietary Name:
Retrovir
Non-Proprietary Name:
Zidovudine
Substance Name:
Zidovudine
Usage Information:
This drug is used with other HIV medications to help control HIV infection. It helps to decrease the amount of HIV in your body so your immune system can work better. This lowers your chance of getting HIV complications (such as new infections, cancer) and improves your quality of life. Zidovudine belongs to a class of drugs known as nucleoside reverse transcriptase inhibitors-NRTIs. Zidovudine is used in pregnant women to prevent passing the HIV virus to the unborn baby. This medication is also used in newborns born to mothers infected with HIV to prevent infection in the newborns. Zidovudine is not a cure for HIV infection. To decrease your risk of spreading HIV disease to others, do all of the following: (1) continue to take all HIV medications exactly as prescribed by your doctor, (2) always use an effective barrier method (latex or polyurethane condoms/dental dams) during all sexual activity, and (3) do not share personal items (such as needles/syringes, toothbrushes, and razors) that may have contacted blood or other body fluids. Consult your doctor or pharmacist for more details.
11-Digit NDC Billing Format:
49702021326
Billing Unit:
ML - Billing unit of "milliliter" is used when a product is measured by its liquid volume.
NDC to RxNorm Crosswalk:
  • RxCUI: 108396 - Retrovir 200 MG in 20 ML Injection
  • RxCUI: 108396 - 20 ML zidovudine 10 MG/ML Injection [Retrovir]
  • RxCUI: 108396 - 20 ML AZT 10 MG/ML Injection [Retrovir]
  • RxCUI: 108396 - Retrovir 10 MG/ML per 20 ML Injection
  • RxCUI: 108396 - Retrovir 200 MG per 20 ML Injection
    • Product Type:
    Human Prescription Drug
    Labeler Name:
    Viiv Healthcare Company
    Dosage Form:
    Injection, Solution - A liquid preparation containing one or more drug substances dissolved in a suitable solvent or mixture of mutually miscible solvents that is suitable for injection.
    Administration Route(s):
  • Intravenous - Administration within or into a vein or veins.
    • Active Ingredient(s):
  • ZIDOVUDINE 10 mg/mL
    • Pharmacologic Class(es):
  • Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor - [EPC] (Established Pharmacologic Class)
  • Nucleoside Reverse Transcriptase Inhibitors - [MoA] (Mechanism of Action)
    • Sample Package:
    No
    FDA Application Number:
    NDA019951
    Marketing Category:
    NDA - A product marketed under an approved New Drug Application.
    Start Marketing Date:
    11-04-2010
    Listing Expiration Date:
    12-31-2024
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    NDC HCPCS Crosswalk

    This crosswalk is intended to help the public understand which drug products (identified by NDCs) are assigned to which HCPCS billing codes.

    NDC 49702-213-26 HCPCS crosswalk information with package details and bill units information.

    NDC Billing CodeHCPCS CodeHCPCS Code Desc.DosagePackage SizePackage QuantityBillable UnitsBillable Units / Pkg
    49702021326J3485Zidovudine10 MG20520100

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 49702-213-26?

    The NDC Packaged Code 49702-213-26 is assigned to a package of 5 vial, single-use in 1 carton / 20 ml in 1 vial, single-use (49702-213-01) of Retrovir, a human prescription drug labeled by Viiv Healthcare Company. The product's dosage form is injection, solution and is administered via intravenous form.

    Is NDC 49702-213 included in the NDC Directory?

    Yes, Retrovir with product code 49702-213 is active and included in the NDC Directory. The product was first marketed by Viiv Healthcare Company on November 04, 2010 and its listing in the NDC Directory is set to expire on December 31, 2024 if the product is not updated or renewed by the manufacturer.

    What is the NDC billing unit for package 49702-213-26?

    The contents of this package are billed per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.

    What is the 11-digit format for NDC 49702-213-26?

    The 11-digit format is 49702021326. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    5-3-249702-213-265-4-249702-0213-26